A Study of Surufatinib Combined With Serplulimab in the Treatment of Advanced Solid Tumors With Neuroendocrine Differentiation That Failed Standard Therapy
NA
Enrolled patients with advanced solid tumors with neuroendocrine differenti...
Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)
PHASE2
This is a Phase II Randomized Controlled PILOT clinical study. The purpose ...